Literature DB >> 1987522

Upper respiratory tract infections in young children: duration of and frequency of complications.

E R Wald1, N Guerra, C Byers.   

Abstract

This study was performed to determine the usual duration of community-acquired viral upper respiratory tract infections and the incidence of complications (otitis media/sinusitis) of these respiratory tract infections in infancy and early childhood. Children in various forms of child-care arrangements (home care, group care, and day care) were enrolled at birth and observed for 3 years. Families were telephoned every 2 weeks to record on a standardized form the type and severity of illnesses experienced during the previous interval. Only children remaining in their original child-care group for the entire study period were compared. The mean duration of an upper respiratory tract infection varied between 6.6 days (for 1- to 2-year-old children in home care) and 8.9 days (for children younger than 1 year in day care). The percentage of apparently simple upper respiratory tract infections that lasted more than 15 days ranged from 6.5% (for 1- to 3-year-old children in home care) to 13.1% (for 2- to 3-year-old children in day care). Children in day care were more likely than children in home care to have protracted respiratory symptoms. Of 2741 respiratory tract infections recorded for the 3-year period, 801 (29.2%) were complicated by otitis media. During the first 2 years of life, children in any type of day care were more likely than children in home care to have otitis media as a complication of upper respiratory tract infection. In year 3, the risk of otitis media was similar in all types of child care.

Entities:  

Mesh:

Year:  1991        PMID: 1987522

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  52 in total

1.  Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children.

Authors:  E L Anderson; F K Newman; H F Maassab; R B Belshe
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

2.  National trends in visit rates and antibiotic prescribing for children with acute sinusitis.

Authors:  Daniel J Shapiro; Ralph Gonzales; Michael D Cabana; Adam L Hersh
Journal:  Pediatrics       Date:  2010-12-27       Impact factor: 7.124

Review 3.  The role of allergy in sinus disease. Children and adults.

Authors:  Z Pelikan
Journal:  Clin Rev Allergy Immunol       Date:  1998 Spring-Summer       Impact factor: 8.667

Review 4.  Prevention of recurrent respiratory tract infections in children using a ribosomal immunotherapeutic agent: a clinical review.

Authors:  Jean Bousquet; Alessandro Fiocchi
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 5.  The role of multiplex PCR in respiratory tract infections in children.

Authors:  Jens Christian Krause; Marcus Panning; Hartmut Hengel; Philipp Henneke
Journal:  Dtsch Arztebl Int       Date:  2014-09-19       Impact factor: 5.594

6.  An international medico-economic survey of 2007 children with recurrent nasopharyngitis and acute otitis media. Preliminary bindings.

Authors:  W Elies; Y Pletan
Journal:  Drugs       Date:  1997       Impact factor: 9.546

7.  Respiratory tract infection is the major cause of the ambulatory visits in children.

Authors:  PeiFen Liao; MinSho Ku; KoHuang Lue; HaiLun Sun
Journal:  Ital J Pediatr       Date:  2011-09-15       Impact factor: 2.638

8.  Do symptoms and initial clinical probability predict the radiological diagnosis of acute sinusitis in children?

Authors:  C Cyr; R Racette; C P Leduc; C Blais
Journal:  Paediatr Child Health       Date:  2001-10       Impact factor: 2.253

9.  Prevention of recurrent rhinopharyngitis in at-risk children in France: a cost-effectiveness model for a nonspecific immunostimulating bacterial extract (OM-85 BV).

Authors:  Jean-Jacques Pessey; Françoise Mégas; Benoît Arnould; Florence Baron-Papillon
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

Review 10.  Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Authors:  Jack B Anon; Michael R Jacobs; Michael D Poole; Paul G Ambrose; Mark S Benninger; James A Hadley; William A Craig
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.